Minerva Biotechnologies
ID: 5291374Minerva Biotechnologies is a clinical-stage biopharmaceutical company focused on developing immunotherapies for solid tumor cancers and cellular therapies for regenerative medicine.
8
Funding Rounds
$113.7m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Minerva Biotechnologies has raised a total of $29.6m in funding over 8 rounds.
Key Insights:
- MINERVA BIOTECHNOLOGIES Corp Funding Round, February 2022: $25m
- Minerva Biotechnologies funding round, November 2010: $4.6m
- MINERVA BIOTECHNOLOGIES Corp funding round, October 2019: $12m
- MINERVA BIOTECHNOLOGIES Corp funding round, April 2019: $12m
- MINERVA BIOTECHNOLOGIES Corp funding round, October 2018: $31.2m
- MINERVA BIOTECHNOLOGIES Corp funding round, October 2014: $30m
- MINERVA BIOTECHNOLOGIES Corp funding round, November 2010: $5.9m
- MINERVA BIOTECHNOLOGIES CORP funding round, February 2010: $5m
Industries
Minerva Biotechnologies is active in the following industries: